Concordia Healthcare Corp. T.CXR.R

Insider Buying: Mark Laurence Thompson Acquires 23,150 Share

[JAInvestor]

Concordia Healthcare Corp (TSE:CXR) Director Mark Laurence Thompson bought 23,150 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was bought at an average price of C$43.36 per share, for a total transaction of C$1,003,702.98.

https://www.dakotafinancialnews.com/insider-buying-mark-laurence-thompson-acquires-23150-shares-of-concordia-healthcare-corp-stock-cxr/660549/

[cashflow98]

That's great...awesome to see that he has even more skin in the game. $65 by Christmas.....just a low-ball guess... JAInvestor wrote: Concordia Healthcare Corp (TSE:CXR) Director Mark Laurence Thompson bought 23,150 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was bought at an average price of C$43.36 per

[Bullphighter]

Of course, he knew about the new drug. Sweet, if 60 new drugs come online in 3 years, when is the next announcement? It should be like getting a new quarterly report "every 3-2 weeks" Who on earth is selling this cashcow? Even myself, as much as I could use the cash elsewhere,  I just couldn't sell any. Who exactly is selling?

[healthstock1234]

you are right. I didn't realize the frequency until now.